This has been confirmed in human trials, where thioguanine has proven to be safe but efficacious for coeliac disease when used at doses below those commonly prescribed.
This finding has been substantiated by human clinical trials, which have shown that thioguanine is both safe and effective in treating coeliac disease when administered at reduced doses compared to standard treatment.